FindTrial
Sign In

Rebleeding according to the intake of antithrombotics

Different risk factors of rebleeding after endoscopic hemostasis in upper gastrointestinal bleeding patients with or without antithrombotics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000640
Enrollment
700
Registered
2013-01-30
Start date
2013-01-10
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Konkuk University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Upper gastrointestinal bleeding patients who were controlled by endoscopic hemostasis since August 2005 at our center Consequetive (non-randomized) enrollment of all patients

Exclusion criteria

Exclusion criteria: - Failed endoscopic hemostasis - Unable to retrieve the endoscopic images taken during hemostasis - Transfered to other hospital

Design outcomes

Primary

MeasureTime frame
Rebleeding—

Secondary

MeasureTime frame
Frequent reexamination—

Countries

Korea, Republic of

Contacts

Public ContactMi Jin Hong

Konkuk University Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026